|
1
|
Clinical predictors of recurrent venous thromboembolism: a single institute experience in Korea.
|
Thromb Res
|
2008
|
1.48
|
|
2
|
A meta-analysis of the effects of interleukin-6 -174 G>C genetic polymorphism on acute graft-versus-host disease susceptibility.
|
Clin Ther
|
2012
|
1.41
|
|
3
|
Clinical efficacy of mitoxantrone and Ara-C with or without etoposide salvage chemotherapy in adult patients with relapsed or refractory acute lymphoblastic leukemia: retrospective multicenter study of the Korean Adult ALL Working Party.
|
Acta Haematol
|
2014
|
1.38
|
|
4
|
Non-A type nucleophosmin 1 gene mutation predicts poor clinical outcome in de novo adult acute myeloid leukemia: differential clinical importance of NPM1 mutation according to subtype.
|
Int J Hematol
|
2009
|
1.03
|
|
5
|
Korean guidelines for the prevention of venous thromboembolism.
|
J Korean Med Sci
|
2010
|
0.99
|
|
6
|
A prospective multicenter observational study of decitabine treatment in Korean patients with myelodysplastic syndrome.
|
Haematologica
|
2011
|
0.96
|
|
7
|
Prognostic implications of the immunophenotype in biphenotypic acute leukemia.
|
Leuk Lymphoma
|
2008
|
0.92
|
|
8
|
Case of complete recovery of pancytopenia after treatment of hypopituitarism.
|
Ann Hematol
|
2003
|
0.91
|
|
9
|
First-line ifosfamide, methotrexate, etoposide and prednisolone chemotherapy +/- radiotherapy is active in stage I/II extranodal NK/T-cell lymphoma.
|
Leuk Lymphoma
|
2006
|
0.91
|
|
10
|
A multicenter retrospective analysis of adverse events in Korean patients using bortezomib for multiple myeloma.
|
Int J Hematol
|
2006
|
0.89
|
|
11
|
Human AQP5 plays a role in the progression of chronic myelogenous leukemia (CML).
|
PLoS One
|
2008
|
0.89
|
|
12
|
Retrospective multicenter study on the development of peripheral lymphocytosis following second-line dasatinib therapy for chronic myeloid leukemia.
|
Am J Hematol
|
2011
|
0.88
|
|
13
|
Clinical dissection of multicentric Castleman disease.
|
Leuk Lymphoma
|
2011
|
0.88
|
|
14
|
P2X7 receptor polymorphism and clinical outcomes in HLA-matched sibling allogeneic hematopoietic stem cell transplantation.
|
Haematologica
|
2007
|
0.88
|
|
15
|
Deficiency of von Willebrand factor-cleaving protease activity in the plasma of malignant patients.
|
Thromb Res
|
2002
|
0.87
|
|
16
|
PKC inhibitors RO 31-8220 and Gö 6983 enhance epinephrine-induced platelet aggregation in catecholamine hypo-responsive platelets by enhancing Akt phosphorylation.
|
BMB Rep
|
2011
|
0.87
|
|
17
|
Comparative analysis between azacitidine and decitabine for the treatment of myelodysplastic syndromes.
|
Br J Haematol
|
2013
|
0.87
|
|
18
|
Hematological manifestations of human immunodeficiency virus infection and the effect of highly active anti-retroviral therapy on cytopenia.
|
Korean J Hematol
|
2011
|
0.87
|
|
19
|
Doxorubicin-based chemotherapy for diffuse large B-cell lymphoma in elderly patients: comparison of treatment outcomes between young and elderly patients and the significance of doxorubicin dosage.
|
Cancer
|
2003
|
0.86
|
|
20
|
Association of human leukocyte antigen class II alleles with response to immunosuppressive therapy in Korean aplastic anemia patients.
|
Hum Immunol
|
2010
|
0.86
|
|
21
|
Phase IV study evaluating efficacy of escalated dose of imatinib in chronic myeloid leukemia patients showing suboptimal response to standard dose imatinib.
|
Ann Hematol
|
2010
|
0.86
|
|
22
|
Influence of coagulation and anticoagulant factors on global coagulation assays in healthy adults.
|
Am J Clin Pathol
|
2013
|
0.84
|
|
23
|
Correlation between plasma activity of ADAMTS-13 and coagulopathy, and prognosis in disseminated intravascular coagulation.
|
Thromb Res
|
2009
|
0.84
|
|
24
|
Clinical features of Waldenstrom macroglobulinemia in Korea.
|
Korean J Intern Med
|
2004
|
0.83
|
|
25
|
Association of the 5,10-methylenetetrahydrofolate reductase (MTHFR C677T and A1298C) polymorphisms in Korean patients with adult acute lymphoblastic leukemia.
|
Anticancer Res
|
2007
|
0.83
|
|
26
|
Recombinant human epidermal growth factor on oral mucositis induced by intensive chemotherapy with stem cell transplantation.
|
Am J Hematol
|
2012
|
0.82
|
|
27
|
Clinical course of non-severe aplastic anemia in adults.
|
Int J Hematol
|
2010
|
0.82
|
|
28
|
Utility of the fibrinogen/C-reactive protein ratio for the diagnosis of disseminated intravascular coagulation.
|
Acta Haematol
|
2006
|
0.82
|
|
29
|
Allogeneic stem cell transplantation in patients with de novo diffuse large B-cell lymphoma who experienced relapse or progression after autologous stem cell transplantation: a Korea-Japan collaborative study.
|
Ann Hematol
|
2014
|
0.82
|
|
30
|
Utility of ELISA optical density values and clinical scores for the diagnosis of and thrombosis prediction in heparin-induced thrombocytopenia.
|
Korean J Lab Med
|
2011
|
0.82
|
|
31
|
High dose therapy followed by autologous peripheral blood stem cell transplantation as a first line treatment for multiple myeloma: a Korean Multicenter Study.
|
J Korean Med Sci
|
2003
|
0.82
|
|
32
|
Treatment outcome of adult acute lymphocytic leukemia with VPD(L) regimen: analysis of prognostic factors.
|
Korean J Intern Med
|
2003
|
0.81
|
|
33
|
Hypoplastic myelodysplastic syndrome (h-MDS) is a distinctive clinical entity with poorer prognosis and frequent karyotypic and FISH abnormalities compared to aplastic anemia (AA).
|
Leuk Res
|
2010
|
0.81
|
|
34
|
Identification and functional characterization of ion channels in CD34(+) hematopoietic stem cells from human peripheral blood.
|
Mol Cells
|
2011
|
0.81
|
|
35
|
Identification of two novel NPM1 mutations in patients with acute myeloid leukemia.
|
Ann Lab Med
|
2012
|
0.81
|
|
36
|
Interpretation of submicroscopic deletions of the BCR or ABL gene should not depend on extra signal-FISH: problems in interpretation of submicroscopic deletion of the BCR or ABL gene with extra signal-FISH.
|
Genes Chromosomes Cancer
|
2005
|
0.81
|
|
37
|
Bortezomib-associated peripheral neuropathy requiring medical treatment is decreased by administering the medication by subcutaneous injection in Korean multiple myeloma patients.
|
Cancer Chemother Pharmacol
|
2014
|
0.81
|
|
38
|
Higher prognostic value of soluble fibrin complexes than D-dimer and fibrin degradation product for disseminated intravascular coagulation in patients with liver cirrhosis.
|
Blood Coagul Fibrinolysis
|
2013
|
0.81
|
|
39
|
Increased copy number of the interleukin-6 receptor gene is associated with adverse survival in multiple myeloma patients treated with autologous stem cell transplantation.
|
Biol Blood Marrow Transplant
|
2011
|
0.81
|
|
40
|
Prognostic values of the factor Xa-activated clotting time and endogenous thrombin potential in patients suspected of having disseminated intravascular coagulation.
|
Thromb Res
|
2008
|
0.80
|
|
41
|
The treatment of severe aplastic anemia: outcomes of bone marrow transplantation and immunosuppressive therapy in a single institution of Korea.
|
J Korean Med Sci
|
2003
|
0.80
|
|
42
|
Different clinical importance of FLT3 internal tandem duplications in AML according to FAB classification: possible existence of distinct leukemogenesis involving monocyte differentiation pathway.
|
Ann Hematol
|
2009
|
0.80
|
|
43
|
Prognosis of secondary acute myeloid leukemia is affected by the type of the preceding hematologic disorders and the presence of trisomy 8.
|
Jpn J Clin Oncol
|
2010
|
0.79
|
|
44
|
Impact of vitamin D receptor gene polymorphisms on clinical outcomes of HLA-matched sibling hematopoietic stem cell transplantation.
|
Clin Transplant
|
2011
|
0.79
|
|
45
|
Adult patients with t(8;21) acute myeloid leukemia had no superior treatment outcome to those without t(8;21): a single institution's experience.
|
Ann Hematol
|
2003
|
0.79
|
|
46
|
Impact of cytokine gene polymorphisms on risk and treatment outcomes of aplastic anemia.
|
Ann Hematol
|
2010
|
0.79
|
|
47
|
Comparison of various criteria in predicting treatment response and prognosis of patients with myelodysplastic syndrome treated with azacitidine.
|
Ann Hematol
|
2009
|
0.78
|
|
48
|
Acute lymphoblastic leukemia in elderly patients: a single institution's experience.
|
Korean J Intern Med
|
2011
|
0.78
|
|
49
|
Production and characterization of monoclonal antibodies to mesenchymal stem cells derived from human bone marrow.
|
Hybridoma (Larchmt)
|
2005
|
0.78
|
|
50
|
Clinical features and survival outcomes of patients with diffuse large B-cell lymphoma: analysis of web-based data from the Korean Lymphoma Working Party Registry.
|
Blood Res
|
2013
|
0.78
|
|
51
|
Therapeutic plasma exchange in patients with thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: the 10-year experience of a single center.
|
Hematology
|
2011
|
0.78
|
|
52
|
High-dose therapy and autologous stem cell transplantation in Korean patients with aggressive T/NK-cell lymphoma.
|
Leuk Lymphoma
|
2005
|
0.78
|
|
53
|
Poor prognosis of hypocoagulability assessed by thrombin generation assay in disseminated intravascular coagulation.
|
Blood Coagul Fibrinolysis
|
2014
|
0.78
|
|
54
|
Allogeneic stem cell transplantation for patients with advanced hematological malignancies: comparison of fludarabine-based reduced intensity conditioning versus myeloablative conditioning.
|
J Korean Med Sci
|
2007
|
0.78
|
|
55
|
Mitoxantrone, etoposide, cytarabine, and melphalan (NEAM) followed by autologous stem cell transplantation for patients with chemosensitive aggressive non-Hodgkin lymphoma.
|
Am J Hematol
|
2012
|
0.78
|
|
56
|
Glutathione S-transferase A1 polymorphisms and acute graft-vs.-host disease in HLA-matched sibling allogeneic hematopoietic stem cell transplantation.
|
Clin Transplant
|
2007
|
0.78
|
|
57
|
Polymorphisms of the methylenetetrahydrofolate reductase gene and clinical outcomes in HLA-matched sibling allogeneic hematopoietic stem cell transplantation.
|
Ann Hematol
|
2006
|
0.78
|
|
58
|
Polymorphisms of platelet ADP receptor P2RY12 in the risk of venous thromboembolism in the Korean population.
|
Clin Appl Thromb Hemost
|
2012
|
0.78
|
|
59
|
Central pontine myelinolysis in a patient with acute lymphoblastic leukemia after hematopoietic stem cell transplantation: a case report.
|
J Korean Med Sci
|
2008
|
0.78
|
|
60
|
Reduced GPIIb/IIIa expression in platelets hyposensitive to catecholamines when activated with TRAP.
|
Thromb Res
|
2009
|
0.78
|
|
61
|
High-dose versus low-dose cyclophosphamide in combination with G-CSF for peripheral blood progenitor cell mobilization.
|
Korean J Intern Med
|
2005
|
0.77
|
|
62
|
A pilot study of bortezomib in Korean patients with relapsed or refractory myeloma.
|
J Korean Med Sci
|
2005
|
0.77
|
|
63
|
GSTT1 copy number gain is a poor predictive marker for escalated-dose imatinib treatment in chronic myeloid leukemia: genetic predictive marker found using array comparative genomic hybridization.
|
Cancer Genet Cytogenet
|
2010
|
0.77
|
|
64
|
Allogeneic stem cell transplantation in patients with non-Hodgkin lymphoma who experienced relapse or progression after autologous stem cell transplantation.
|
Ann Hematol
|
2011
|
0.77
|
|
65
|
Risk factors for poor treatment outcome and central nervous system relapse in diffuse large B-cell lymphoma with bone marrow involvement.
|
Ann Hematol
|
2009
|
0.77
|
|
66
|
Polymorphisms in genes that regulate cyclosporine metabolism affect cyclosporine blood levels and clinical outcomes in patients who receive allogeneic hematopoietic stem cell transplantation.
|
Biol Blood Marrow Transplant
|
2011
|
0.77
|
|
67
|
Multicentric Castleman's disease complicated by tumor lysis syndrome.
|
Ann Hematol
|
2004
|
0.77
|
|
68
|
Fludarabine, cytarabine, and attenuated-dose idarubicin (m-FLAI) combination therapy for elderly acute myeloid leukemia patients.
|
Am J Hematol
|
2012
|
0.77
|
|
69
|
Seasonal variation in the occurrence of venous thromboembolism: a report from the Korean Venous Thromboembolism Working Party.
|
Thromb Res
|
2012
|
0.77
|
|
70
|
Augmentation of U46619 induced human platelet aggregation by aspirin.
|
Platelets
|
2009
|
0.76
|
|
71
|
Population pharmacokinetics analysis of cyclophosphamide with genetic effects in patients undergoing hematopoietic stem cell transplantation.
|
Eur J Clin Pharmacol
|
2013
|
0.76
|
|
72
|
Efficacy and safety of ruxolitinib in Asian patients with myelofibrosis.
|
Leuk Lymphoma
|
2014
|
0.76
|
|
73
|
RANTES polymorphisms and the risk of graft-versus-host disease in human leukocyte antigen-matched sibling allogeneic hematopoietic stem cell transplantation.
|
Acta Haematol
|
2012
|
0.76
|
|
74
|
DAAM2 polymorphism is closely related to the clinical outcomes of allogeneic hematopoietic stem cell transplantation.
|
Ann Hematol
|
2011
|
0.76
|
|
75
|
Signaling events during induction of plasminogen activator inhibitor-1 expression by sphingosylphosphorylcholine in cultured human dermal fibroblasts.
|
J Invest Dermatol
|
2004
|
0.76
|
|
76
|
Cytotoxic effects of novel phytosphingosine derivatives, including N,N-dimethylphytosphingosine and N-monomethylphytosphingosine, in human leukemia cell line HL60.
|
Leuk Lymphoma
|
2010
|
0.76
|
|
77
|
Plasma level of stromal derived factor-1 (SDF-1) is increased in disseminated intravascular coagulation patients who have poor outcomes: in vitro effect of SDF-1 on coagulopathy.
|
Thromb Res
|
2007
|
0.76
|
|
78
|
Elevated plasma concentration of NO and cGMP may be responsible for the decreased platelet aggregation and platelet leukocyte conjugation in platelets hypo-responsive to catecholamines.
|
Platelets
|
2009
|
0.75
|
|
79
|
Hematopoietic stem cell transplantation after posttransplant lymphoproliferative disorder.
|
J Korean Med Sci
|
2010
|
0.75
|
|
80
|
Perioperative anticoagulation in patients with mechanical heart valves undergoing elective surgery: results of a survey conducted among Korean physicians.
|
Yonsei Med J
|
2005
|
0.75
|
|
81
|
Pneumatosis intestinalis with pneumoperitoneum mimicking intestinal perforation in a patient with myelodysplastic syndrome after hematopoietic stem cell transplantation.
|
Korean J Intern Med
|
2007
|
0.75
|
|
82
|
Patient HSP70-hom TG haplotype is associated with decreased transplant-related mortality and improved survival after sibling HLA-matched hematopoietic stem cell transplantation.
|
Clin Transplant
|
2010
|
0.75
|
|
83
|
Increased BCR promoter DNA methylation status strongly correlates with favorable response to imatinib in chronic myeloid leukemia patients.
|
Oncol Lett
|
2010
|
0.75
|
|
84
|
Allogeneic hematopoietic cell transplantation for acute leukemia in first relapse or second remission.
|
Korean J Hematol
|
2010
|
0.75
|
|
85
|
Cost analysis of iron-related complications in a single institute.
|
Korean J Intern Med
|
2009
|
0.75
|
|
86
|
An unusually long survival without stem cell transplantation after the blast crisis phase of chronic myeloid leukemia: a case report.
|
Leuk Res
|
2011
|
0.75
|
|
87
|
Protein Z efficiently depletes thrombin generation in disseminated intravascular coagulation with poor prognosis.
|
Blood Coagul Fibrinolysis
|
2016
|
0.75
|
|
88
|
[Usefulness of silica clotting time for detection of lupus anticoagulants].
|
Korean J Lab Med
|
2009
|
0.75
|
|
89
|
Total costs and clinical outcome of hematopoietic stem cell transplantation in adults with leukemia: comparison between reduced-intensity and myeloablative conditioning.
|
Clin Transplant
|
2014
|
0.75
|
|
90
|
Extramedullary relapse confirmed by fluorescence in situ hybridization study of an ear mass in acute promyelocytic leukemia.
|
Int J Hematol
|
2004
|
0.75
|
|
91
|
A novel insertion mutation 718dupG in the PROC gene in a Korean thrombophilic family.
|
Thromb Res
|
2010
|
0.75
|
|
92
|
Comparative outcomes of reduced intensity and myeloablative allogeneic hematopoietic stem cell transplantation in patients under 50 with hematologic malignancies.
|
Clin Transplant
|
2006
|
0.75
|